This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hedge Funds' Best Picks Show the Way for 2012

Health Care

The health care sector was a popular one in the third quarter for hedge fund managers looking for merger-arbitrage opportunities. Takeover targets like Kinetic Concepts, Cephalon and Medco Health Solutions (MHS) were snatched up during the quarter, increasing health care weightings for several hedge fund managers.

The merger activity is one way to explain the strong performance of the health care sector this year. Health care names in the S&P 500 are up 6.1% overall, according to Capital IQ, the second best sector performance this year. The outlook for health care stocks, though, leaves plenty to be desired. After notching only 7% earnings growth in the third quarter, analysts are only calling for 5% earnings growth for the sector in 2012. In addition, health care companies will be in limbo as President Obama's health care reform bill gets challenged in the courts.

If they weren't playing M&A activity in the sector, hedge fund managers were selling for the most part. Pfizer (PFE) was a popular name to sell, with David Tepper's Appaloosa Management and David Einhorn's Greenlight Capital reducing their holdings in the drugmaker. Tepper also sold shares of fellow drug stock Merck (MRK), as well as Medtronic (MDT) and UnitedHealth Group (UNH).

Elsewhere, Steven Cohen's SAC Capital sold out of Dendreon (DNDN), which had been one of the hedge fund's largest holdings before the stock crumbled. Cohen's fund also sold shares of Tenet Healthcare (THC), Express Scripts (ESRX) and Novartis (NVS), among others.

Meanwhile, both Blue Ridge Capital and Omega Advisors cut their holdings in Teva Pharmaceutical (TEVA), although that may be due to the fact that the company's shares fell very sharply in August.
7 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $126.44 0.00%
BP $41.29 0.00%
BAC $17.03 0.00%
C $55.37 0.00%
GOOG $523.40 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs